Stay updated on Nivolumab and Ipilimumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Ipilimumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Ipilimumab in Melanoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    New related-topic entries were added for Melanoma and MedlinePlus Genetics. These appear under a related topics section to aid context and navigation.
    Difference
    0.1%
    Check dated 2026-08-23T21:51:22.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Three items were removed from the Related topics section: Melanoma, related topics:, and MedlinePlus Genetics. This reduces the set of related topic links shown on the study page.
    Difference
    0.1%
    Check dated 2026-08-16T21:56:34.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Melanoma and related topics (MedlinePlus Genetics) are added and the page revision updated to v3.6.5; the Investigator Inquiry Form is deleted and the prior revision v3.6.4 is superseded.
    Difference
    0.1%
    Check dated 2026-08-09T11:31:56.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Melanoma, the related topics section, and the MedlinePlus Genetics link were removed, reducing visible disease context and navigation options on the trial detail page.
    Difference
    0.1%
    Check dated 2026-08-01T23:45:49.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    A Melanoma topic was added and a Related topics entry for MedlinePlus Genetics was included. The page revision tag was updated from v3.6.3 to v3.6.4.
    Difference
    0.1%
    Check dated 2026-07-26T00:21:00.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page removed the explicit disease label 'Melanoma' and the Related Topics section (including MedlinePlus Genetics). This changes how the study's focus is described and how related reading resources are surfaced.
    Difference
    0.1%
    Check dated 2026-07-11T17:02:20.000Z thumbnail image

Stay in the know with updates to Nivolumab and Ipilimumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Ipilimumab in Melanoma Clinical Trial page.